All anti-HBc-positive, HBsAg-negative dialysis patients on the transplant waiting list should be regarded as at risk of hepatitis B reactivation post-renal transplantation - Report of three cases from a single centre

Nephrology Dialysis Transplantation

Volumn 21, Issue 11, 2006, Pages 3316-3319

  Roberts, Rhys Clwyd ^a   Lane, Catherine ^a   Hatfield, Peter ^a   Clutterbuck, Elaine ^a   Atkins, Mark ^b   Brown, Ashley ^a   Dorling, Anthony ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Anti Hbc antibody; HBV DNA; Hepatitis B; Renal transplantation; Viral reactivation; Waiting list

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; VIRUS DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG SUBSTITUTION; FOLLOW UP; HEMODIALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER BIOPSY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK FACTOR; SURGICAL RISK; VIRUS REACTIVATION;

HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; TISSUE AND ORGAN PROCUREMENT; VIRUS ACTIVATION; WAITING LISTS;

EID: 33749983702     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl401     Document Type: Article

References (12)

1. Fabrizi F, Martin P, Ponticelli C. Hepatitis B virus and renal transplantation. Nephron 2002; 90: 241-251
2. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2: 1104-1108
3. Recommendations for preventing transmission of infections among chronic hemodialysis patients. Morbidity and Mortality Weekly report: Centers for Disease Control and Prevention, 2001.
4. Wachs ME, Amend WJ, Ascher NL et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 1995; 59: 230-234
5. Marcellin P, Giostra E, Martinot-Peignoux M et al. Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology 1991; 100: 1432-1434
6. Blanpain C, Knoop C, Delforge ML et al. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: Report on three cases and review of the literature. Transplantation 1998; 66: 883-886
7. Oesterreicher C, Hammer J, Koch U et al. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int 1995; 48: 1967-1971
8. Minuk GY, Sun DF, Greenberg R et al. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology 2004; 40: 1072-1077
9. Fabrizi F, Messa PG, Lunghi G et al. Occult hepatitis B virus infection in dialysis patients: A multicentre survey. Aliment Pharmacol Ther 2005; 21: 1341-1347
10. Fornairon S, Pol S, Legendre C et al. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation 1996; 62: 297-299
11. Pirson Y, Alexandre GP, Ypersele C. Long-term effect of hbs antigenemia on patient survival after renal transplantation. N Engl J Med 1977; 296: 194-196
12. Mathurin P, Mouquet C, Poynard T et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29: 257-263